Literature DB >> 29687361

Tildrakizumab-asmn: What's in a Name?

Eric J Yang1,2, Kristen M Beck3, Wilson Liao3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29687361     DOI: 10.1007/s40257-018-0357-6

Source DB:  PubMed          Journal:  Am J Clin Dermatol        ISSN: 1175-0561            Impact factor:   7.403


× No keyword cloud information.
  1 in total

Review 1.  Profile of tildrakizumab-asmn in the treatment of moderate-to-severe plaque psoriasis: evidence to date.

Authors:  Kristen M Beck; Isabelle M Sanchez; Eric J Yang; Wilson Liao
Journal:  Psoriasis (Auckl)       Date:  2018-08-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.